 FARMINGTON HILLS, Mich., Nov. 21, 2022 GLOBE NEWSWIRE -- Ocuphire Pharma, Inc. Nasdaq: OCUP, a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of refractive and retinal eye disorders, today announced that Mina Sooch, MBA, founder and CEO will present at several investor conferences in November and December, including the BTIG Ophthalmology Day, Alliance Global Partners AGP Biotech Conference, Ophthalmology Innovation Summit OIS XII, Cantor Dermatology, Ophthalmology Medtech Conference, and the Planet MicroCap Conference, being held on the following dates: 